semaglutide schizophrenia Blockbuster weight-loss drugs linked to lower risk of addiction, schizophrenia, dementia, and more Efficacy and safety of semaglutide

Furthermore, there was a propensity score matching to reduce bias

The results, which were presented this week at the European Congress on Obesity in Dublin, are among the first indication that the weight loss induced by the new GLP-1 agonist drugs like Wegovy also brings heart health benefits something scientists expected but do not yet have much comprehensive data to prove

The conflicting findings highlight the early stage of research into the neurological effects of GLP-1 drugs

This is a moment where these treatments are really entering the mainstream, Standen said

Avoid high-fat meals, large portions, and foods known to cause GI distress independently

What to Expect During the First Few Weeks Many individuals experience an adjustment phase when starting WEGOVY 0.25MG INJECTION: Appetite changes: Smaller portion sizes may feel sufficient due to enhanced satiety